K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Eur J Epidemiol. 2023 Jun;38(6):643-656. doi: 10.1007/s10654-023-00981-x. Epub 2023 Mar 27.
Insomnia and short/long sleep duration increase the risk of AMI, but their interaction with each other or with chronotype is not well known. We investigated the prospective joint associations of any two of these sleep traits on risk of AMI. We included 302 456 and 31 091 participants without past AMI episodes from UK Biobank (UKBB; 2006-10) and the Trøndelag Health Study (HUNT2; 1995-97), respectively. A total of 6 833 and 2 540 incident AMIs were identified during an average 11.7 and 21.0 years follow-up, in UKBB and HUNT2, respectively. Compared to those who reported normal sleep duration (7-8 h) without insomnia symptoms, the Cox proportional hazard ratios (HRs) for incident AMI in UKBB among participants who reported normal, short and long sleep duration with insomnia symptoms were 1.07 (95% CI 0.99, 1.15), 1.16 (95% CI 1.07, 1.25) and 1.40 (95% CI 1.21, 1.63), respectively. The corresponding HRs in HUNT2 were 1.09 (95% CI 0.95, 1.25), 1.17 (95% CI 0.87, 1.58) and 1.02 (95% CI 0.85, 1.23). The HRs for incident AMI in UKBB among evening chronotypes were 1.19 (95% CI 1.10, 1.29) for those who had insomnia symptoms, 1.18 (95% CI 1.08, 1.29) for those with short sleep duration, and 1.21 (95% CI 1.07, 1.37) for those with long sleep duration, compared to morning chronotypes without another sleep symptom. The relative excess risk for incident AMI in UKBB due to interaction between insomnia symptoms and long sleep duration was 0.25 (95% CI 0.01, 0.48). Insomnia symptoms with long sleep duration may contribute more than just an additive effect of these sleep traits on the risk of AMI.
失眠和短/长睡眠时长会增加 AMI 的风险,但它们之间的相互作用或与昼夜节律类型的关系尚不清楚。我们研究了这两种睡眠特征中任意两种特征对 AMI 风险的前瞻性联合关联。
我们纳入了分别来自英国生物银行(UKBB;2006-10 年)和特隆德拉格健康研究(HUNT2;1995-97 年)的 302456 名和 31091 名没有既往 AMI 发作的参与者。在 UKBB 和 HUNT2 中,分别在平均 11.7 年和 21.0 年的随访期间,共发现了 6833 例和 2540 例新发 AMI。与报告正常睡眠时长(7-8 小时)且无失眠症状的参与者相比,在 UKBB 中,报告正常、短睡眠时长和长睡眠时长且有失眠症状的参与者中,新发 AMI 的 Cox 比例风险比(HR)分别为 1.07(95%CI 0.99,1.15)、1.16(95%CI 1.07,1.25)和 1.40(95%CI 1.21,1.63)。在 HUNT2 中,相应的 HR 分别为 1.09(95%CI 0.95,1.25)、1.17(95%CI 0.87,1.58)和 1.02(95%CI 0.85,1.23)。在 UKBB 中,与无其他睡眠症状的早型昼夜节律者相比,有失眠症状的晚型昼夜节律者新发 AMI 的 HR 为 1.19(95%CI 1.10,1.29),短睡眠时长者为 1.18(95%CI 1.08,1.29),长睡眠时长者为 1.21(95%CI 1.07,1.37)。与无失眠症状和长睡眠时长的参与者相比,由于失眠症状与长睡眠时长之间的相互作用,UKBB 中 AMI 新发的相对超额风险为 0.25(95%CI 0.01,0.48)。长睡眠时长伴失眠症状可能比这些睡眠特征对 AMI 风险的单纯相加效应贡献更大。